focus -WSS

focus

author：hotspot 2025-09-30 17:02:57 - browse：75

U.S. legislation that would sever ties with Chinese drugmakers would jeopardize the drug supply for millions of American patients if it’s passed, the biotechnology industry’s main trade group has told Congress.

Congress is considering legislation, called the BIOSECURE Act, that would make it difficult for Chinese contract development and manufacturing organizations to do business with biotechnology companies that work with the U.S. federal government. Biotechs hire Chinese CDMOs, as they’re often called, for services that include product manufacturing, development, formulation, packaging, and distribution.

The BIOSECURE Act would stop the federal government from contracting with, or providing grants to, companies that do business with so-called Chinese “companies of concern.” The impact of the legislation would depend in large part on who is in the White House. The White House’s Office of Management and Budget would determine which companies are blacklisted, but a handful of specific companies would automatically go on that list, including the biotech giant WuXi AppTec.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections
Next article： Rock icon Freddie Mercury pre

WSS

New company forms to vet health AI models, root out weaknesses

'A game

Eat, drink, but be wary — 4 foods that interact with medications

Eli Lilly CEO gives to Mike Pence presidential super PAC

The struggle to figure out which patients 'deserve' Wegovy

Grad students accuse University of California of wage theft

focus

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Wikipedia

At least 13 dead in Texas as scorching temps continue

Eat, drink, but be wary — 4 foods that interact with medications

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Medicare to pay more for cardiac rehab in hospital outpatient clinics

State Dept. review finds Biden bears some blame for Afghanistan failures

Patients, doctors press FTC to beef up hospital merger scrutiny

Apple is now the first public company to be valued at $3 trillion

Eat, drink, but be wary — 4 foods that interact with medications

At least 13 dead in Texas as scorching temps continue

Midwives could help bridge maternal health disparities in the U.S.

Wikipedia

Why the quest to eradicate polio has stumbled

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

Jailed Russian opposition leader Alexey Navalny gets 19 more years in prison

Transgender sports debate: Physicians say bans are health issue

Senate bill would ban some hospital facility fees

Calls for Trump's election interference trial to be televised part of long debate

knowledge

focus

focus

hotspot